"10.1371_journal.pone.0134587","plos one","2015-08-12T00:00:00Z","Morgan Kruse; Rebecca Wildner; Gisoo Barnes; Monique Martin; Udo Mueller; Francesco Lo-Coco; Ashutosh Pathak","Optum, Cambridge, Massachusetts, United States of America; Teva Pharmaceuticals, Frazer, Pennsylvania, United States of America; MapiGroup, Uxbridge, United Kingdom; Teva Pharmaceuticals, Ulm, Germany; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy","Conceived and designed the experiments: MK RW GB MM UM FL AP. Performed the experiments: MK RW MM. Analyzed the data: MK RW MM. Contributed reagents/materials/analysis tools: GB UM FL AP. Wrote the paper: MK RW GB MM UM FL AP.","The authors have read the journals policy and have the following competing interests: The study was funded by Teva Pharmaceuticals. Morgan Kruse is a full time employee of Optum and has no other competing interests to declare. Rebecca Wildner is a full time employee of MapiGroup and has no other competing interests to declare. Gisoo Barnes is a full time employee of Teva and has no other competing interests to declare. Monique Martin is a full time employee of MapiGroup and has no competing interests to declare. Udo Mueller is a full time employee of Teva and has no other competing interests to declare. Lo Coco received consultancy honoraria from Teva and has been in the speaker bureau of Teva and Lundbeck. Ashutosh Pathak is a full time employee of Teva and own stocks of the company and has no other competing interests to declare. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","08","Morgan Kruse","MK",7,FALSE,7,3,3,7,TRUE,TRUE,FALSE,0,NA,FALSE
